Effect of ICRF-187 on the pulmonary damage induced by hyperoxia in the rat
- 30 September 1992
- journal article
- Published by Elsevier in Toxicology
- Vol. 74 (2-3) , 185-202
- https://doi.org/10.1016/0300-483x(92)90138-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycinInflammation Research, 1989
- Oxygen tolerance in mice following exposure to butylated hydroxytolueneToxicology and Applied Pharmacology, 1988
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) ratsToxicology and Applied Pharmacology, 1988
- Antioxidant Defenses in the LungAnnual Review of Physiology, 1986
- Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea.Journal of Clinical Investigation, 1984
- American College of Chest Physicians (ACCP)--National Heart, Lung, and Blood Institute (NHLBI) Conference on oxygen therapyArchives of internal medicine (1960), 1984
- Oxygen Radicals and Lung Injury: The State of the ArtChest, 1983
- Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.Journal of Clinical Investigation, 1981
- Protection from Oxygen Toxicity with EndotoxinJournal of Clinical Investigation, 1980